AIM calls for a Pharmaceutical Strategy shaped to ensure and promote solidarity and sustainable healthcare in the European Union


After the launch of the European Pharmaceutical Strategy roadmap and public consultation by the European Commission, AIM, the International Association of Mutual Benefit Societies, has articulated a set of recommendations to rebalance pharmaceutical markets in Europe.

AIM calls for the European Pharmaceutical Strategy to be first and foremost a health strategy to support universal healthcare coverage. It must be a strategy that shapes a pharmaceutical industry for solidarity and sustainable healthcare in Europe.

The recommendations are available here.